(MedPage Today) -- As federal regulators have been drawing up new rules for the 340B drug discount program, a pitched battle has broken out between hospitals and drug manufacturers who say the program is now bloated and badly regulated.
REUTERS - spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.
By S.Z. Berg
NEW YORK (MainStreet)--The Food and Drug Administration (FDA) announced a proposal to revise drug labeling regulations for generic drugs to create parity among brand name and generic drug manufacturers. The revised rule would allow...
WASHINGTON (MedPage Today) -- The FDA has expanded the indications for oral lubiprostone (Amitiza) to include constipation in chronic pain patients taking opioids, according to the drug's manufacturers.
The United States said on Tuesday it was considering its response to the Supreme Court ruling that U.S. drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in the country.